S6K1 also participates in the development of brain tumor pathogenesis [45], and the gene expression patterns of S6Ks have been evaluated in brain and central neuron system tumors, indicating that S6K1 rather than S6K2 exhibits elevated expression in brain tumors and is associated with poor prognosis of patients [41]. Here, RPS6KB2 is linked to brain neoplasm.